Asset Management
Compare Stocks
2 / 10Stock Comparison
GAM vs IVZ
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
GAM vs IVZ — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Asset Management | Asset Management |
| Market Cap | $1.51B | $11.92B |
| Revenue (TTM) | $252M | $6.38B |
| Net Income (TTM) | $202M | $-243M |
| Gross Margin | 100.0% | 43.2% |
| Operating Margin | 97.5% | -10.9% |
| Forward P/E | 6.0x | 10.4x |
| Total Debt | $2M | $10.12B |
| Cash & Equiv. | $70K | $1.98B |
GAM vs IVZ — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| General American In… (GAM) | 100 | 207.0 | +107.0% |
| Invesco Ltd. (IVZ) | 100 | 336.6 | +236.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GAM vs IVZ
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GAM carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 0.74
- Rev growth 180.6%, EPS growth -36.1%
- 195.4% 10Y total return vs IVZ's 22.1%
IVZ is the clearest fit if your priority is dividends and momentum.
- 3.1% yield; 4-year raise streak; the other pay no meaningful dividend
- +93.1% vs GAM's +39.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 180.6% NII/revenue growth vs IVZ's 5.1% | |
| Value | Lower P/E (6.0x vs 10.4x) | |
| Quality / Margins | Efficiency ratio 0.0% vs IVZ's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.74 vs IVZ's 1.67, lower leverage | |
| Dividends | 3.1% yield; 4-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +93.1% vs GAM's +39.3% | |
| Efficiency (ROA) | Efficiency ratio 0.0% vs IVZ's 0.5% |
GAM vs IVZ — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
GAM vs IVZ — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
GAM leads this category, winning 3 of 4 comparable metrics.
Income & Cash Flow (Last 12 Months)
IVZ is the larger business by revenue, generating $6.4B annually — 25.3x GAM's $252M. GAM is the more profitable business, keeping 97.5% of every revenue dollar as net income compared to IVZ's -4.4%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $252M | $6.4B |
| EBITDAEarnings before interest/tax | $105,782 | $1.2B |
| Net IncomeAfter-tax profit | $202M | -$243M |
| Free Cash FlowCash after capex | $0 | $1.9B |
| Gross MarginGross profit ÷ Revenue | +100.0% | +43.2% |
| Operating MarginEBIT ÷ Revenue | +97.5% | -10.9% |
| Net MarginNet income ÷ Revenue | +97.5% | -4.4% |
| FCF MarginFCF ÷ Revenue | — | +22.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +5.8% | +34.2% |
Valuation Metrics
Evenly matched — GAM and IVZ each lead in 2 of 4 comparable metrics.
Valuation Metrics
On an enterprise value basis, GAM's 6.2x EV/EBITDA is more attractive than IVZ's 16.3x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.5B | $11.9B |
| Enterprise ValueMkt cap + debt − cash | $1.5B | $20.1B |
| Trailing P/EPrice ÷ TTM EPS | 6.02x | -16.77x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 10.44x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 6.17x | 16.34x |
| Price / SalesMarket cap ÷ Revenue | 6.01x | 1.87x |
| Price / BookPrice ÷ Book value/share | 0.91x | 0.94x |
| Price / FCFMarket cap ÷ FCF | — | 8.27x |
Profitability & Efficiency
GAM leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
GAM delivers a 12.0% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-2 for IVZ. GAM carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to IVZ's 0.78x. On the Piotroski fundamental quality scale (0–9), IVZ scores 6/9 vs GAM's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +12.0% | -1.7% |
| ROA (TTM)Return on assets | +11.9% | -0.9% |
| ROICReturn on invested capital | +12.4% | -2.3% |
| ROCEReturn on capital employed | +16.3% | -2.6% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 |
| Debt / EquityFinancial leverage | 0.00x | 0.78x |
| Net DebtTotal debt minus cash | $2M | $8.1B |
| Cash & Equiv.Liquid assets | $69,600 | $2.0B |
| Total DebtShort + long-term debt | $2M | $10.1B |
| Interest CoverageEBIT ÷ Interest expense | — | -6.19x |
Total Returns (Dividends Reinvested)
GAM leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GAM five years ago would be worth $19,443 today (with dividends reinvested), compared to $10,825 for IVZ. Over the past 12 months, IVZ leads with a +93.1% total return vs GAM's +39.3%. The 3-year compound annual growth rate (CAGR) favors GAM at 25.8% vs IVZ's 21.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +10.5% | +0.4% |
| 1-Year ReturnPast 12 months | +39.3% | +93.1% |
| 3-Year ReturnCumulative with dividends | +99.2% | +79.8% |
| 5-Year ReturnCumulative with dividends | +94.4% | +8.2% |
| 10-Year ReturnCumulative with dividends | +195.4% | +22.1% |
| CAGR (3Y)Annualised 3-year return | +25.8% | +21.6% |
Risk & Volatility
GAM leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
GAM is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than IVZ's 1.67 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GAM currently trades 98.3% from its 52-week high vs IVZ's 90.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.74x | 1.67x |
| 52-Week HighHighest price in past year | $66.18 | $29.61 |
| 52-Week LowLowest price in past year | $51.26 | $14.10 |
| % of 52W HighCurrent price vs 52-week peak | +98.3% | +90.6% |
| RSI (14)Momentum oscillator 0–100 | 63.5 | 69.4 |
| Avg Volume (50D)Average daily shares traded | 28K | 5.1M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
IVZ is the only dividend payer here at 3.10% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | $29.72 |
| # AnalystsCovering analysts | — | 28 |
| Dividend YieldAnnual dividend ÷ price | — | +3.1% |
| Dividend StreakConsecutive years of raises | — | 4 |
| Dividend / ShareAnnual DPS | — | $0.83 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +15.6% |
GAM leads in 4 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 1 category is tied.
GAM vs IVZ: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is GAM or IVZ a better buy right now?
For growth investors, General American Investors Company, Inc.
(GAM) is the stronger pick with 180. 6% revenue growth year-over-year, versus 5. 1% for Invesco Ltd. (IVZ). General American Investors Company, Inc. (GAM) offers the better valuation at 6. 0x trailing P/E, making it the more compelling value choice. Analysts rate Invesco Ltd. (IVZ) a "Hold" — based on 28 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — GAM or IVZ?
Over the past 5 years, General American Investors Company, Inc.
(GAM) delivered a total return of +94. 4%, compared to +8. 2% for Invesco Ltd. (IVZ). Over 10 years, the gap is even starker: GAM returned +195. 4% versus IVZ's +22. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — GAM or IVZ?
By beta (market sensitivity over 5 years), General American Investors Company, Inc.
(GAM) is the lower-risk stock at 0. 74β versus Invesco Ltd. 's 1. 67β — meaning IVZ is approximately 126% more volatile than GAM relative to the S&P 500. On balance sheet safety, General American Investors Company, Inc. (GAM) carries a lower debt/equity ratio of 0% versus 78% for Invesco Ltd. — giving it more financial flexibility in a downturn.
04Which is growing faster — GAM or IVZ?
By revenue growth (latest reported year), General American Investors Company, Inc.
(GAM) is pulling ahead at 180. 6% versus 5. 1% for Invesco Ltd. (IVZ). On earnings-per-share growth, the picture is similar: General American Investors Company, Inc. grew EPS -36. 1% year-over-year, compared to -235. 6% for Invesco Ltd.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — GAM or IVZ?
General American Investors Company, Inc.
(GAM) is the more profitable company, earning 97. 5% net margin versus -4. 4% for Invesco Ltd. — meaning it keeps 97. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GAM leads at 97. 5% versus -10. 9% for IVZ. At the gross margin level — before operating expenses — GAM leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — GAM or IVZ?
In this comparison, IVZ (3.
1% yield) pays a dividend. GAM does not pay a meaningful dividend and should not be held primarily for income.
07Is GAM or IVZ better for a retirement portfolio?
For long-horizon retirement investors, General American Investors Company, Inc.
(GAM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 74), +195. 4% 10Y return). Invesco Ltd. (IVZ) carries a higher beta of 1. 67 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (GAM: +195. 4%, IVZ: +22. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between GAM and IVZ?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: GAM is a small-cap high-growth stock; IVZ is a mid-cap income-oriented stock. IVZ pays a dividend while GAM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.